Skip to main content
SpringerLink
Log in

Dermatika

  • Chapter
Arzneiverordnungs- Report 2014

  • 1545 Accesses

Zusammenfassung

Die Verordnungen von Dermatika halten sich seit Jahren auf stabilem Niveau. Am häufigsten werden Corticosteroide verordnet. Auf sie entfällt 2013 fast die Hälfte der verordneten Tagesdosen aller Dermatika. Deutlich seltener verordnet werden dermatologische Antimykotika (13%), Aknemittel (8%), Psoriasismittel (7%), Antiinfektiva (7%), Warzenmittel (7%) und Wundbehandlungsmittel (6%). Alle übrigen Gruppen hatten einen Verordnungsanteil von unter 5%.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ågren MS, Ostenfeld U, Kallehave F, Gong Y, Raffn K, Crawford ME, Kiss K, Friis-Møller A, Gluud C, Jorgensen LN (2006): A randomized, double-blind, placebo-controlled multicenter trial evaluating topical zinc oxide for acute open wounds following pilonidal disease excision. Wound Repair Regen 4: 526–535

    Google Scholar 

  • Alsterholm M, Flytström I, Bergbrant IM, Faergemann J (2010): Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol 90: 52–57

    PubMed  Google Scholar 

  • Alston SJ, Cohen BA, Braun M (2003): Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics 111: 201–203

    PubMed  Google Scholar 

  • Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P et al. (1994): Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30: 977–981

    PubMed  Google Scholar 

  • Ammon HPT, Sabieraj J, Kaul R (1996): Kamille. Mechanismus der antiphlogistischen Wirkung von Kamillenextrakten und -inhaltsstoffen. Dtsch Apoth Ztg 136: 1821–1834

    Google Scholar 

  • Anonymus (2002): New treatments for actinic keratoses. Medical Letter 44: 57–58

    Google Scholar 

  • Antille C, Saurat JH, Lübbe J (2004): Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 140: 457–460

    PubMed  Google Scholar 

  • Arican O, Sasmaz S, Ozbulu O (2006): Increased suicidal tendency in a case of psoriasis vulgaris under acitretin treatment. J Eur Acad Dermatol Venerol 20: 464–465

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (1999): Nutzen und Risiken durch Fumarsäure- Ester bei der Therapie der Psoriasis. Dtsch Ärztebl 96: A–721

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2005): Myopathie nach Tacrolimus-Salbe (Protopic?). Dtsch Ärztebl 102: A313–8

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2006): Psychiatrische Reaktionen nach Terninafin (Lamisil?). Dtsch Ärztebl 103: A343–2

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2011): Multiple aktinische Keratosen (Carcinomata in situ der Haut) nach langjähriger topischer Anwendung von Tacrolimus (Protopic®). Dtsch Ärztebl 108: A545–A546

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2013a): Rhabdomyolyse nach Isotretinoin. Dtsch Ärztebl 110: A 240.

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2013b): Nokardiose bei Lymphopenie durch Fumaderm® (Aus der UAW-Datenbank). . Dtsch Ärztebl 110: A 1220–1221

    Google Scholar 

  • Aziz Z, Abu SF, Chong NJ (2012): A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns 38: 307–318

    PubMed  Google Scholar 

  • Balak DM, Oostveen AM, Bousema MT, Venema AW, Arnold WP, Seyger MM, Thio HB (2013): Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands. Br J Dermatol 168: 1343–1347

    PubMed  Google Scholar 

  • Baran R, Kaoukhov A (2005): Topical antifungal drugs fort he treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venerol 19: 21–29

    Google Scholar 

  • Barker JNWN (2011): Methotrexate or fumarates: which is the best oral treatment for psoriasis? Br J Dermatol 164: 69–5

    Google Scholar 

  • Bell-Syer SEM, Hart R, Crawford F, Torgerson DJ, Tyrell W, Russell I (2006): Oral treatments for fungal infections of the skin of the foot (Cochrane Review). In: The Cochrane Library, Issue 1 2006. Oxford: Update Software

    Google Scholar 

  • Berrios RL, Arbiser JL (2011): Effectiveness of gentian violet and similar products commonly used to treat pyodermas. Dermatol Clin 29: 69–73

    PubMed  Google Scholar 

  • Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA. Multinational Study Group (2003): Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double- blind, parallel group study. Brit Med J 326: 1367–1373

    Google Scholar 

  • Bewley A for the Dermatology Working Group (2008): Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol 158: 917–920

    Google Scholar 

  • Biogen Idec GmbH (2013): Wichtige Hinweise an medizinische Fachkreise: Fumaderm® initial / Fumaderm® – Vermeidung des Risikos opportunistischer Infektionen durch Einhaltung regelmäßiger Laborkontrollen und weiterer Warnhinweise während der Therapie. http://www.akdae.de/Arzneimittelsicherheit/RHB/20130625.pdf

  • Biro K, Thaci D, Ochsendorf FR, Kaufmann R, Boehncke W-H (2003): Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis 49: 80–84

    PubMed  Google Scholar 

  • Boguniewicz M, Leung DY (2010): Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125: 4–13

    PubMed  Google Scholar 

  • Booij MT, van De Kerkhof PC (2011): Acitretin revisited in the era of biologics. J Dermatolog Treat 22: 86–89

    PubMed  Google Scholar 

  • Bradley M, Cullum N, Sheldon T (1999): The debridement of chronic wounds: a systematic review. Health Technol Assess 3: 1–78

    Google Scholar 

  • Braun R (Hrsg.) (2014): Arzneistoff-Profile, Basisinformation über arzneilich wirksame Wirkstoffe. Stammlieferung 1982 mit 1. bis 27. Erg.-Lieferung 2014, Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn

    Google Scholar 

  • Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC, Landthaler M (2005): Dermatologie und Venerologie, 5. Auflage. Springer Medizin Verlag, Heidelberg

    Google Scholar 

  • Bristow IR, Baran R (2006): Topical and oral combination therapy for toenail onychomycosis. An updated review. J Am Podiatr Med Associat 96: 116–119

    Google Scholar 

  • Bundesinstitut für Arzneimittel und Medizinprodukte (2013): Informationsbrief zu oralen ketoconazolhaltigen Arzneimitteln (Nizoral® Tabletten): Ruhen der Zulassung wegen schwerer Leberschädigungen. http://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RHB/2013/info-nizoral.html

  • Bundesministerium für Gesundheit und Soziale Sicherung (2004): Bekanntmachung des Gemeinsamen Bundesausschusses über eine Änderung der Richtlinien über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel-Richtlinien) vom 15. Juni 2004. BAnz. Nr. 156 (S. 18 661) vom 20.08.2004, https://www.g-ba.de/institution/sys/suche/ergebnis/?suche[suchbegriff]=crinohermal&suche[offset]=0&suche[sortierung]=relevanz&suche[kategorie]=alle

  • Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H (2009): Contact dermatitis due to use of Octenisept(R) in wound care. J Dtsch Dermatol Ges 7: 759–765

    PubMed  Google Scholar 

  • Casciano J, Amaya K, Doyle J, Arikian S, Shear N, Haspel M, Kahler K (2003): Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Manag Care 12: 47–54

    PubMed  Google Scholar 

  • Chen SL, Yan J, Wang FS (2010): Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials. J Dermatolog Treat 21: 144–156

    PubMed  Google Scholar 

  • Christiansen B (1988): Untersuchungen über die Wirksamkeit eines Hautdesinfektionsmittels mit kationenaktivem Zusatz. Zbl Bakt Hyg B 186: 368–374

    Google Scholar 

  • Chroni E, Monastirli A, Tsambaos D (2010): Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf 33: 25–34

    PubMed  Google Scholar 

  • Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB Jr, Feldman SR (2007): Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol 6: 495–498

    PubMed  Google Scholar 

  • Crawford F, Young P, Godfrey C, Bell-Syer SEM, Hart R, Brunt E, Russel I (2002): Oral treatments for toenail onychomycosis. Arch Dermatol 138: 811–816

    PubMed  Google Scholar 

  • Crawford F, Hollis S (2007): Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2007 Jul 18 (3): CD00143–4

    Google Scholar 

  • Cunningham A, Griffiths P, Leone P, Mindel A, Patel R, Stanberry L, Whitley R (2012): Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol 53: 6–11

    PubMed Central  PubMed  Google Scholar 

  • Dall’oglio F, D’Amico V, Nasca MR, Micali G (2012): Treatment of cutaneous warts: an evidence- based review. Am J Clin Dermatol 13: 73–96

    PubMed  Google Scholar 

  • Darkes MJM, Scott LJ, Goa KL (2003): Terbinafine. A review of its use in onychomycosis in adults. Am J Clin Dermatol 4: 39–65

    PubMed  Google Scholar 

  • Del Rosso JQ, Pillai R, Moore R (2010): Absence of degradation of tretinoin when benzoyl peroxide is combined with an optimized formulation of tretinoin gel (0.05%). J Clin Aesthet Dermatol 3: 26–28

    PubMed Central  PubMed  Google Scholar 

  • Deutsche Dermatologische Gesellschaft (2009a): Topische Dermatotherapie mit Glukokortikoiden – Therapeutischer Index. AWMF-Leitlinien-Register Nr. 013/034, http://www.awmf.org/uploads/tx_szleitlinien/013-034.pdf

  • Deutsche Dermatologische Gesellschaft (2009b): Psoriasis des behaarten Kopfes. AWMF-Leitlinien- Register Nr. 013/074, http://www.awmf.org/uploads/tx_szleitlinien/013-074.pdf

  • Deutsche Dermatologische Gesellschaft (2011a): Leitlinie zur Therapie der Psoriasis vulgaris – Update 2011. AWMF-Leitlinien-Register Nr. 013/001, http://www.awmf.org/uploads/tx_szleitlinien/013-001l_S3_Psoriasis_vulgaris_Therapie_01.pdf

  • Deutsche Dermatologische Gesellschaft (2011b): Behandlung der Akne. AWMF-Leitlinien- Register Nr. 013/017, www.awmf.org/uploads/tx_szleitlinien/013-017l_S2k_Behandlung_der_Akne_2011-10-Korrektur.pdf

  • Deutsche Dermatologische Gesellschaft (2011c): Leitlinie zur Behandlung der aktinischen Keratosen C44.X. AWMF-Leitlinien-Register Nr. 013/041, http://www.awmf.org/uploads/tx_szleitlinien/013-041l_S1_Aktinische_Keratose_2012-01.pdf

  • Deutsche Dermatologische Gesellschaft, Berufsverband Deutscher Dermatologen (2009): Therapie des atopischen Ekzems mit Calcimeurin-Inhibitoren. AWMF-Leitlinien-Register Nr. 013/037, http://www.awmf.org/uploads/tx_szleitlinien/013-037.pdf

  • Deutsche Dermatologische Gesellschaft, Deutschsprachige Mykologische Gesellschaft (2008): Tinea der freien Haut. AWMF-Leitlinien-Register Nr. 013-002, http://www.awmf.org/uploads/tx_szleitlinien/013-002.pdf

  • Deutsche Dermatologische Gesellschaft (DDG) et al (2008): Neurodermitis, AWMF-Leitlinien- Register Nr. 013/027, http://www.awmf.org/uploads/tx_szleitlinien/013-027l_S2e_Neurodermitis_01.pdf

  • Deutsche Gesellschaft für Phlebologie (2008): Diagnostik und Therapie des Ulcus cruris venosum. AWMF-Leitlinien-Register Nr. 037/009, http://www.awmf.org/uploads/tx_szleitlinien/037-009_S3_Diagnostik_und_Therapie_des_Ulcus_cruris_venosum_lang_08-2008_08-2013.pdf

  • Dissemond J, Gerber V, Kramer A, Riepe G, Strobal R, Vasel-Biergans A, Eberlein T (2009): Praxisorientierte Empfehlung zur Behandlung kritisch-kolonisierter und lokal infizierter Wunden mit Polihexanid. Wundmanagement 3: 62–68

    Google Scholar 

  • Dissemond J, Augustin M, Eming SA, Goerge T, Horn T, Karrer S., Schumann H, Stücker M, for the working group for wound healing (AGW) of the German Society of Dermatology (DDG) (2014): Modern wound care – practical aspects of non-interventional topical treatment of patients with chronic wounds. J Dtsch Ges Dermatol, published online: 12 May 2014, DOI: 10.1111/ddg.12351, http://onlinelibrary.wiley.com/doi/10.1111/ddg.12351/pdf

  • Dobie D, Gray J (2004): Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 89: 74–77

    PubMed Central  PubMed  Google Scholar 

  • Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Webster SB, Whitaker DC, Butler B, Lowery BJ, Raimer SA, Krafchik BR, Olsen E, Weston WL (1996): Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. J Am Acad Dermatol 35: 615–619

    PubMed  Google Scholar 

  • Drucker CR (2012): Update on topical antibiotics in dermatology. Dermatol Ther 25: 6–11

    PubMed  Google Scholar 

  • Eberlein T, Assadian O (2010): Clinical use of polihexanide on acute and chronic wounds for antisepsis and decontamination. 23 (Suppl): 45–51

    Google Scholar 

  • Eberlein T, Haemmerle G, Signer M, Gruber Moesenbacher U, Traber J, Mittlboeck M, Abel M, Strohal R (2012): Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds. J Wound Care 21: 12–20

    Google Scholar 

  • Ebner F, Heller A, Rippke F, Tausch I (2002): Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol 3: 427–433

    PubMed  Google Scholar 

  • Eckhard M, Lengler A, Liersch J, Bretzel RG, Mayser P (2007): Fungal foot infections in patients with diabetes mellitus – results of two independent investigations. Mycoses 50 (Suppl 2): 14–19

    PubMed  Google Scholar 

  • Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Sidbury R (2014): Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014 May 7. pii: S0190-9622(14)01257–2. doi: 10.1016/j.jaad.2014.03.023. [Epub ahead of print]

    Google Scholar 

  • Eifler-Bollen R, Fluhr JW (2005): Antimikrobiell wirksame Magistralrezepturen. Stellenwert in der Praxis und kritische Anmerkungen. Hautarzt 56: 752–758

    PubMed  Google Scholar 

  • El Sayed F, Ammoury A, Dhaybi R, Bazex J (2006): Rosaceiform eruption to pimecrolimus. J Am Acad Dermatol 54: 548–550

    PubMed  Google Scholar 

  • Ermis U, Weis J, Schulz JB (2013): PML in a patient treated with fumaric acid. N Engl J Med 368: 1657–1658

    PubMed  Google Scholar 

  • Erbagci Z (2004): Topical therapy for dermatophytoses. Should corticosteroids be included? Am J Clin Dermatol 5: 375–384

    PubMed  Google Scholar 

  • European Medicines Agency (EMA) (2006): European Medicines Agency recommends cautious use of Protopic/Protopy and Elidel. http://www.emea.europa.eu/pdfs/general/direct/pr/9888206en.pdf

  • Fallah Arani S, Neumann H, Hop WC, Thio HB (2011): Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial. Br J Dermatol 164:855–861

    PubMed  Google Scholar 

  • Fallen RS, Gooderham M (2012): Rosacea: update on management and emerging therapies. Skin Therapy Lett 17: 1–4

    PubMed  Google Scholar 

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2010): Topical calcineurin inhibitors: Literature review. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255139.pdf

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2011): Topical calcineurin inhibitors: Literature review addendum. www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255140.pdf

  • Ference JD, Last AR (2009): Choosing topical corticosteroids. Am Fam Physician 79: 135–140

    PubMed  Google Scholar 

  • Fleischer AB jr, Abramovits W, Breneman D, Jaracz E; US/Canada tacrolimus ointment study group (2007): Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J Dermatol Treat 18: 151–157

    Google Scholar 

  • Fleischer AB, Feldman SR (1999): Prescription of high-potency corticosteroid agents and clotrimazole- betamethasone dipropionate by pediatricians. Clin Ther 10: 1725–1731

    Google Scholar 

  • Fluhr JW, Cavallotti C, Berardesca E (2008): Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol 26: 380–386

    PubMed  Google Scholar 

  • Fluhr JW, Degitz K (2010): Antibiotika, Azelainsäure und Benzoylperoxid in der topische Aknetherapie. J Dtsch Dermatol Ges 8 (Suppl 1): S24–30

    PubMed  Google Scholar 

  • Fölster-Holst R, Latussek E (2007): Synthetic tannins in dermatology – a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol 24: 296–301

    PubMed  Google Scholar 

  • Food and Drug Adminstration (2005): Elidel (pimecrolimus) Cream and Protopic (tacrolimus) Ointment. http://www.fda.gov/cder/drug/advisory/elidel_protopic.htm

  • Food and Drug Adminstration (2014): FDA warns of rare but serious hypersensitivity reactions with certain over-the-counter topical acne products. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM402663.pdf

  • Frankel HC, Qureshi AA (2012): Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Am J Clin Dermatol 13: 113–123

    PubMed  Google Scholar 

  • Franz T, Vögelin E (2012): Aseptic tissue necrosis and chronic inflammation after irrigation of penetrating hand wounds using Octenisept®. J Hand Surg Eur 37: 61–64

    Google Scholar 

  • Friese K, Neumann G, Siebert J (2003): Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis. Arch Gynecol Obstet 268: 194–197

    PubMed  Google Scholar 

  • Garnock-Jones KP, Perry CM (2009): Alitretinoin: in severe chronic hand eczema. Drugs 69: 1625–1634

    PubMed  Google Scholar 

  • Gaspari A, Tyring SK, Rosen T (2009): Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol 8: 467–474

    Google Scholar 

  • Gemeinsamer Bundesausschuss (2014): Richtlinie des Gemeinsamen Bundesausschusses über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel- Richtlinie/AM-RL) in der Fassung vom 18. Dezember 2008/22. Januar 2009, veröffentlicht im Bundesanzeiger 2009, Nr. 49a, zuletzt geändert am 20. März 2014 veröffentlicht BAnz AT 05.05.2014 B2 in Kraft getreten am 6. Mai 2014 https://www.g-ba.de/downloads/62-492-871/AM-RL_2014-03-20_iK-2014-05-06.pdf

  • Gibbs S, Harvey I (2006): Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001781. DOI: 10.1002/14651858.CD001781.pub2.

    PubMed  Google Scholar 

  • Glenn CJ, Kobraei KB, Russo JJ (2011): New-onset psoriasis associated with adalimumab: a report of two cases. Dermatol Online J 17: 1–5

    Google Scholar 

  • Gloor M (1982): Pharmakologie dermatologischer Externa. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  • Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S, Ziegler J (2002): Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 205: 46–53

    PubMed  Google Scholar 

  • González U, Seaton T, Bergus G, Jacobson J, Martínez-Monzón C (2007): Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2007, Issue 4. Art. No.: CD004685. DOI: 10.1002/14651858.CD004685.pub2

    PubMed  Google Scholar 

  • Gorman CR, White SW (2005): Rosaceiform dermatitis as a complication of treatment of facial seborrhoic dermattis with 1% pimecrolimus cream. Arch Dermatol 141: 116–8

    Google Scholar 

  • Griffiths CE, Barker JN (2007): Pathogenesis and clinical features of psoriasis. Lancet 370: 263–271

    PubMed  Google Scholar 

  • Grover C, Arora P, Manchanda V (2012): Comparative evaluation of griseofulvin, terbinafine und fluconazole in the trteatment of tinea capitis. Int J Dermatol 51: 455–458

    PubMed  Google Scholar 

  • Grover C, Khurana A (2012): An update on treatment of onychomycosis. Mycoses 55: 541–551

    PubMed  Google Scholar 

  • Gupta AK (2002): Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis. J Am Pediatr Med Assoc 92: 272–286

    Google Scholar 

  • Gupta AK, Cherman AM, Tyring SK (2005): Viral and nonviral uses of imiquimod: A review. J Cut Med Surg 8: 338–352

    Google Scholar 

  • Gupta AK, Cooper EA (2008): Update in antifungal therapy of dermatophytosis. Mykopathologia 166: 353–367

    Google Scholar 

  • Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM (2004): Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol 5: 225–237

    PubMed  Google Scholar 

  • Hahn C, Röseler S, Fritzsche R, Schneider R, Merk HF (1993): Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis 28: 81–83

    PubMed  Google Scholar 

  • Haugh M, Helou S, Boissel JP, Cribier BJ (2002): Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials. Br J Dermatol 147: 118–121

    PubMed  Google Scholar 

  • Hauschild A, Kähler KC, Egberts F (2006): Moderne Behandlungsoptionen bei aktinischen Keratosen der Haut. Dtsch Med Wochenschr 131: 447–452

    PubMed  Google Scholar 

  • Hendriks AG, Keijsers RR, de Jong EM, Seyger MM, van de Kerkhof PC (2013a): Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review. J Eur Acad Dermatol Venereol 27:399–410

    Google Scholar 

  • Hendriks AG, Keijsers RR, de Jong EM, Seyger MM, van de Kerkhof PC (2013b): Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 27:931–951

    Google Scholar 

  • Hengge UR, Ruzicka T, Schartz RA, Cork MJ (2006): Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54: 1–15

    PubMed  Google Scholar 

  • Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN (2003): Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 149: 363–369

    PubMed  Google Scholar 

  • Hoffmann R, Happle R (2000): Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment. Eur J Dermatol 10: 410–417

    PubMed  Google Scholar 

  • Hornstein OP, Nürnberg E (Hrsg) (1985): Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Georg Thieme Verlag, Stuttgart New York

    Google Scholar 

  • Hund M, Sinkgraven R, Rzany B (2004): Randomisierte, plazebokontrollierte klinische Doppelblindstudie zur Wirksamkeit und Verträglichkeit der oralen Therapie mit Methantheliniumbromid (Vagantin?) bei fokaler Hyperhidrose. J Dtsch Dermatol Ges 2: 43–349

    Google Scholar 

  • Iorizzo M, Piraccini BM, Tosti A (2010): Today's treatments options for onychomycosis. J Dtsch Dermatol Ges 8: 875–879

    PubMed  Google Scholar 

  • Jarvis B, Figgitt DP (2003): Topical 3% diclofenac in 2.5% hyaluronic acid gel. A review of its use in patients with actinic keratoses. Am J Clin Dermatol 4: 203–213

    PubMed  Google Scholar 

  • Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB (1999): Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 5: 2006–2011

    PubMed  Google Scholar 

  • Kakourou T, Uksal U; European Society for Pediatric Dermatology (2010): Guidelines for the management of tinea capitis in children. Pediatr Dermatol 27: 226–228

    PubMed  Google Scholar 

  • Kalavala M, Dohil MA (2011): Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. Am J Clin Dermatol 12: 15–24

    PubMed  Google Scholar 

  • Komericki P, Akkilic-Materna M, Strimitzer T, Aberer W (2011): Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts. Sex Transm Dis 38: 216–218

    PubMed  Google Scholar 

  • Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, Berger M, van der Wouden JC (2012): Interventions for impetigo. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD003261. DOI: 10.1002/14651858.CD003261.pub3

    PubMed  Google Scholar 

  • Koo JYM (2005): New developments in topical sequential therapy for psoriasis. Skin Therapy Lett 10: 1–4

    PubMed  Google Scholar 

  • Korting HC (1995): Dermatotherapie: ein Leitfaden. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  • Korting HC, Schäfer-Korting M., Klövekorn W., Klövekorn G., Martin C., Laux P (1995): Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol 48: 461–465

    PubMed  Google Scholar 

  • Krug M, Oji V, Traupe H, Berneburg M (2009): Ichthyoses – Part 1: Differential diagnosis of vulgar ichthyoses and therapeutic options. J Dtsch Dermatol Ges 7: 511–519

    PubMed  Google Scholar 

  • Küster W, Bohnsack K, Rippke F, Upmeyer HJ, Groll S, Traupe H (1998): Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 196: 217–222

    PubMed  Google Scholar 

  • Küster W (2006): Ichthyosen: Vorschläge für eine verbesserte Therapie. Dtsch Ärztebl 103: A1684–A1689

    Google Scholar 

  • Kujath P, Michelsen A (2008): Wunden – von der Physiologie zum Verband. Dtsch Ärztebl 105: 239–248

    Google Scholar 

  • Kwok CS, Gibbs S, Bennen C, Holland R, Abbott R (2012): Topical treatments for cutaneous warts, Cochrane Database o(Systematic Reviews 2012, Issue 9, Art, No« CD00178L DOr: 10,1002/14651858,CD00178Lpub3

    Google Scholar 

  • Lachapelle JM (2014): A comparison of the irritant and allergenic properties of antiseptics. Eur J Dermatol 24: 3–9

    PubMed  Google Scholar 

  • Lakshmi C, Srinivas CR (2012): Hand eczema: An update. Indian J Dermatol Venereol Leprol 78: 569–582

    PubMed  Google Scholar 

  • Langer A, Rogowski W (2009): Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research 2009, 9: 115 (doi:10.1186/1472-6963-9-115)

    PubMed Central  PubMed  Google Scholar 

  • Langner A, Sheehan-Dare R, Layton A (2007): A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol 21: 311–319

    PubMed  Google Scholar 

  • Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Ågren MS (2007): Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 15: 2–16

    PubMed  Google Scholar 

  • Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R (2005): Treatment options – development of consensus guidelines. J Eur Acad Dermatol Venereol 19 (suppl 1): 25–33

    PubMed  Google Scholar 

  • Lee S, Selva D, Huilgol SC, Goldberg RA, Leibovitch I (2007): Pharmacological treatments for basal cell carcinoma. Drugs 67: 915–934

    PubMed  Google Scholar 

  • Lohde H, Stahlmann R (Hrsg.) (2004): Nadifloxacin – irrationaler Einsatz eines Fluorchinolons zur lokalen Aknetherapie. Zeitschr Chemother 25: 27–29

    Google Scholar 

  • Løkkevik E, Skovlund E, Reitan JB, Hannisdal E, Tanum G (1996): Skin treatment with Bepanthen cream versus no cream during radiotherapy. Acta Oncol 35: 1021–1026

    PubMed  Google Scholar 

  • Longstaff E, von Krogh G (2001): Condyloma eradication: self-therapy with 0.15–0.5% podophyllotoxin versus 20–25% podophyllin preparations–an integrated safety assessment. Regul Toxicol Pharmacol 33: 117–137

    PubMed  Google Scholar 

  • Lopaschuk CR (2013): New approach to managing genital warts. Can Fam Physician 59: 731– 736

    PubMed Central  PubMed  Google Scholar 

  • Magin P, Sullivan J (2010): Suicide attempts in people taking isotretinoin for acne. Br Med J 341: c5866

    Google Scholar 

  • Maiche AG, Gröhn P, Mäki-Hokkonen H (1991): Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30: 395–396

    PubMed  Google Scholar 

  • Mahil SK, Andrews TC, Brierley C, Barker JN, Smith CH (2013): Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature. J Dermatolog Treat 24: 38–49

    PubMed  Google Scholar 

  • Mayser P, Freund V, Budihardja D (2009): Toenail onychomycosis in diabetic patients: issues and managemant. Am J Clin Dermatol 10: 211–220

    PubMed  Google Scholar 

  • McClellan KJ, Noble S (2000): Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 1: 191–199

    PubMed  Google Scholar 

  • McNeil JC, Hulten KG, Kaplan SL, Mason EO (2014): Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother 58: 2878–2883

    PubMed Central  PubMed  Google Scholar 

  • McIntyre WJ, Downs MR, Bedwell SA (2007): Treatment options for actinic keratoses. Am Fam Physician 76: 667–671

    PubMed  Google Scholar 

  • Menezes de Padua CA, Schnuch A, Nink K, Pfahlberg A, Uter W (2008): Allergic contact dermatitis to topical drugs – epidemiological risk assessment. Pharmacoepidemiol Drug Saf 17: 813–821

    Google Scholar 

  • Merk HF (2007): Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 46: 12–18

    PubMed  Google Scholar 

  • Möhrenschlager M, Seidl HP, Ring J, Abeck D (2005): Pediatric tinea capitis. Recognition and management. Am J Clin Dermatol 6: 203–213

    PubMed  Google Scholar 

  • Moore AY (2009): Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatolog Treat 20: 328–335

    PubMed  Google Scholar 

  • Moore ZEH, Cowman S (2013): Wound cleansing for pressure ulcers. Cochrane Database Syst Rev. 2013, Issue 3: CD00498–3. doi: 10.1002/14651858.CD004983.pub3

    Google Scholar 

  • Mosti G (2013): Wound care in venous ulcers. Phlebology 28 (Suppl 1): 79–85

    PubMed  Google Scholar 

  • Müller G, Kramer A (2008): Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. Antimicrob Chemother 61: 1281–1287

    Google Scholar 

  • Muller A, Talon D, Potier A, Belle E, Cappelier G, Bertrand X (2005): Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Critical Care 9: R246–R250

    PubMed Central  PubMed  Google Scholar 

  • Naldi L, Griffiths CEM (2005): Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 152: 597–615

    PubMed  Google Scholar 

  • Niedner R (1998): Kortikoide in der Dermatologie. UNI-MED Verlag, Bremen

    Google Scholar 

  • Niedner R, Ziegenmeyer J (Hrsg) (1992): Dermatika. Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Palfreyman S, Nelson EA, Michaels JA (2007): Dressings for venous leg ulcers: systematic review and mety-analysis. Br Med J 335: 244–248

    Google Scholar 

  • Paller AS, Lebwohl M, Fleischer AB jr, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ; US/Canada Tacrolimus Ointment Study Group (2005): Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 52: 810–822

    Google Scholar 

  • Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ, for the Psoriasis Foundation (2007): National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143: 239–242

    PubMed  Google Scholar 

  • Patel B, Siskin S, Krazmien R, Lebwohl M (1998): Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 38: 1010–1011

    PubMed  Google Scholar 

  • Patel R, Alderson S, Geretti A, Nilsen A, Foley E, Lautenschlager S, Green J, van der Meijden W, Gomberg M, Moi H; IUSTI/WHO Europe (2011): European guideline for the management of genital herpes, 2010. Int J STD AIDS 22: 1–10.

    PubMed  Google Scholar 

  • Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B (2009): European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23 (Suppl 2): 1–70

    PubMed  Google Scholar 

  • Peserico A, Städtler G, Sebastian M, Fernandez RS, Vick K, Bieber T (2008): Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 158: 801–807

    PubMed  Google Scholar 

  • Piatkowski A, Drummer N, Andriessen A, Ulrich D, Pallua N (2011): Randomized controlled single center study comparing a polyhexanide containing bio-cellulose dressing with silver sulfadiazine cream in partial-thickness dermal burns. 37: 800–804

    Google Scholar 

  • Post B, Jänner M (1971): Zur Indikation der Gerbstofftherapie in der Dermatologie. Klinische Erfahrungen mit Tannosynt. Ther Ggw 110: 1477–1494

    PubMed  Google Scholar 

  • Psoriasis-Netzwerk (2014): Tarmed® Teer-Shampoo kommt nicht vor 2016 zurück. Internet: http://www.psoriasis-netz.de/medikamente/allgemein/tarmedr-teer-shampoo-nicht-vor-2016.html

  • Qureshi AA, Fischer MA (2006): Topical calcineurin inhibitors for atopic dermatitis - Balancing clinical benefit and possible risks. Arch Dermatol 142: 633–637

    PubMed  Google Scholar 

  • Rahimi H, Mara T, Costella J, Speechley M, Bohay R (2012): Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 618–627

    PubMed  Google Scholar 

  • Ramos-e-Silva M, Oliveira Lima CM, Casz Schechtman R, Moritz Trope B, Carneiro S (2012): Systemic mycoses in immunodepressed patients (AIDS) Clin Dermatol 30: 616–627

    PubMed  Google Scholar 

  • Rathi SK, D’Souza P (2012): Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol 57: 251–259

    PubMed Central  PubMed  Google Scholar 

  • Ring J, Fröhlich HH (1985): Wirkstoffe in der dermatologischen Therapie, 2. Aufl, Springer- Verlag, Berlin Heidelberg

    Google Scholar 

  • Rotta I, Sanchez A, Gonçalves PR, Otuki MF, Correr CJ (2012): Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. Br J Dermatol 166: 927–933

    PubMed  Google Scholar 

  • Ruzicka T (2006): Methylprednisolone aceponate in eczema and other inflammatory skin disorders – a clinical update. Int J Clin Pract 60: 85–92

    PubMed  Google Scholar 

  • Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, Kaszuba A, Bissonnette R, Varjonen E, Holló P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Harsch M, Maares J (2008): Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 158: 808–817

    PubMed  Google Scholar 

  • Samrao A, Cockerell CJ (2013): Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents. Am J Clin Dermatol 14: 273–237

    Google Scholar 

  • Sapijaszko MJA (2005): Imiquimod 5% cream (Aldara®) in the treatment of basal cell carcinoma. Skin Ther Lett 10: 2–5

    Google Scholar 

  • Schäfer-Korting M, Schmid MH, Korting HC (1996): Topical glucocorticoids with improved risk-benefit ratio. Drug Safety 14: 375–385

    PubMed  Google Scholar 

  • Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY (2010): Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125: 39–49

    PubMed  Google Scholar 

  • Schneider LA, Hinrichs R, Scharfetter-Kochanek K (2007): Indikationen zur UVB-Phototherapie. Dtsch Med Wochenschr 132: 888–891

    PubMed  Google Scholar 

  • Schöfer H, Simonsen L (2010): Fusidic acid in dermatology: an updated review. Eur J Dermatol 20: 6–15

    PubMed  Google Scholar 

  • Schülke & Mayr GmbH (2011): Octenisept® – Ödematöse Schwellungen und Gewebeschädigungen nach Wundspülungen unter Druck - Warnung vor nicht bestimmungsgemäßem Gebrauch Rote Hand Brief 21. Januar 2011, http://www.akdae.de/Arzneimittelsicherheit/RHB/20110127.pdf

  • Schulze-Dirks A, Frosch PJ (1988): Kontaktallergie auf Dexpanthenol. Hautarzt 39: 375–377

    PubMed  Google Scholar 

  • Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR (2011): Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-a inhibitors: The Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol 67: e179–185

    Google Scholar 

  • Sigurgeirsson B, Elewski BE, Rich PA, Opper C, Cai B, Nyirady J, Bakshi R (2006): Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomaized, double-blind comparison. J Dermatol Treatm 17: 38–44

    Google Scholar 

  • Singal A, Khanna D (2011): Onychomycosis: Diagnosis and management. Indian J Dermatol Venereol Leprol 77: 659–672

    PubMed  Google Scholar 

  • Smith RG (2008): Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage 54: 16–34

    PubMed  Google Scholar 

  • Solares CA, Batra PS, Hall GS, Citardi MJ (2006): Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 27: 161–165

    PubMed  Google Scholar 

  • Stille W, Brodt HR, Groll AH, Just-Nübling G (2005): Antibiotika-Therapie. Klinik und Praxis der antiinfektiösen Behandlung, 11. Auflage. Schattauer, Stuttgart-New York

    Google Scholar 

  • Strömberg HE, Ågren MS (1984): Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 111: 461–468

    PubMed  Google Scholar 

  • Subissi A, Monti D, Togni G, Mailland F (2010): Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs 70: 2133–2152

    PubMed  Google Scholar 

  • Sunderkötter C, Herrmann M, Jappe U (2006): Antimikrobielle Therapie in der Dermatologie. J Dtsch Dermatol Ges 4: 10–26

    Google Scholar 

  • Sundström A, Alfredsson L, Sjölin-Forsberg G, Gerdén B, Bergman U, Jokinen J (2010): Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. Br Med J 341: c5812

    Google Scholar 

  • Sweetser MT, Dawson KT, Bozic C (2013): Manufacturer's response to case reports of PML. N Engl J Med 368: 1659–161

    Google Scholar 

  • Tadicherla S, Ross K, Shenefelt PD, Fenske NA (2009): Topical corticosteroids in dermatology. J Drugs Dermatol 8: 1093–1105

    PubMed  Google Scholar 

  • Tennis P, Gelfand JM, Rothman KJ (2011): Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol 165: 465–473

    PubMed  Google Scholar 

  • Thaçi D, Schöfer H (2005): Topische Antibiotika zur Therapie von Hautinfektionen. Hautarzt 56: 381–396

    Google Scholar 

  • Thaçi D, Weisenseel P, Philipp S, Rosenbach T, Rotterdam S, Augustin M, Neureither M, Reich K (2013): Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS). J Dtsch Dermatol Ges 11: 429–435

    PubMed  Google Scholar 

  • Thielitz A, AbdeL-Naser MB, Fluhr JW, Zouboulis CC, Gollnick H (2010): Topische Retinoide bei Akne – eine evidenzbasierte Übersicht. J Dtsch Dermatol Ges 8 (Suppl 1): S15–23

    PubMed  Google Scholar 

  • Udompataikul M, Limpa-o-vart D (2012): Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study. J Drugs Dermatol 11: 366–374

    PubMed  Google Scholar 

  • Uter W, Geier J, Fuchs T (2000): Contact allergy to polidocanol, 1992 to 1999. J All Clin Immunol 106: 1203–1204

    Google Scholar 

  • Valente Duarte de Sousa IC (2014): Novel pharmacological approaches for the treatment of acne vulgaris. Expert Opin Investig Drugs 2: 1–22

    Google Scholar 

  • van de Kerkhof PC, Kragballe K, Segaert S, Lebwohl M; International Psoriasis Council (2011): Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol 25: 1130–139

    CAS  PubMed  Google Scholar 

  • van Oosten BW, Killestein J, Barkhof F, Polman CH, Wattjes MP (2013): PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med 368: 1658–1659

    CAS  PubMed  Google Scholar 

  • van Steensel MAM (2007): Emerging drugs for ichthyosis. Expert Opin Emerg Drugs 12: 647–656

    PubMed  Google Scholar 

  • van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S (2007): Systematic review of rosacea treatments. J Am Acad Dermatol 56: 107–1015

    Google Scholar 

  • von Krogh G (1978): Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study. Acta Derm Venereol 58: 163–168.

    Google Scholar 

  • Walker F, Adamczyk A, Kellerer C, Belge K, Brück J, Berner T, Merten K, Núnez Gómez N, Neureither M, Röcken M, Ghoreschi K; The study group (2014): Fumaderm? in daily practice for psoriasis - dosing, efficacy and quality of life. Br J Dermatol 2014 May 10. doi: 10.1111/bjd.13098. [Epub ahead of print]

    Google Scholar 

  • Walluf-Blume D (1991): Aufbereitung und Nachzulassung von OTC-Arzneimitteln in den USA 1990. Pharm Ind 53: 152–158

    Google Scholar 

  • Wananukul S, Limpongsanuruk W, Singalavanija S, Wisuthsarewong W (2006): Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J Med Assoc Thai 89: 1654–1658

    PubMed  Google Scholar 

  • Warshaw EM, Fett DD, Bloomfield HE, Grill JP, Nelson DB, Quintero V, Carver SM, Zielke GR, Lederle FA (2005): Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled study. J Am Acad Dermatol 53: 578–584

    PubMed  Google Scholar 

  • Wickline MM (2004): Prevention and treatment of acute radiation dermatitis: a literature review. Oncol Nurs Forum 31: 237–247

    PubMed  Google Scholar 

  • Wilkinson JD (1998): Fusidic acid in dermatology. Br J Dermatol 139 (Suppl 53): 37–40

    PubMed  Google Scholar 

  • Williams H (2002): New treatments for topic dermatitis. Brit Med J 324: 1533–1534

    PubMed Central  PubMed  Google Scholar 

  • Williams HC, Dellavalle RP, Garner S (2012): Acne vulgaris. Lancet 379: 361–372.

    PubMed  Google Scholar 

  • Wohlrab J (2006): Basistherapie der Psoriasis vulgaris. Hautarzt 57: 661–665

    PubMed  Google Scholar 

  • Wolff HH, Kieser M (2007): Hamamelis in children with skin disorders and skin injuries: results of an observational study. Eur J Pediatr 166: 943–948

    PubMed  Google Scholar 

  • Worret WI, Fluhr JW (2006): Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges 4: 293–300

    PubMed  Google Scholar 

  • Wright JB, Lam K, Burrell RE (1998): Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am J Infect Control 26: 572–577

    PubMed  Google Scholar 

  • Yan J, Chen SL, Wang HN, Wu TX (2006): Meta-analysis of 5% imiquimod amd 0,5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology 213: 218–223

    PubMed  Google Scholar 

  • Yates JE, Phifer JB, Flake D (2009): Clinical inquiries. Do nonmedicated topicals relieve childhood eczema? J Fam Pract 58: 280–281

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Prof. Dr. rer. nat. Uwe Fricke

Authors
  1. Prof. Dr. rer. nat. Uwe Fricke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fricke, U. (2014). Dermatika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs- Report 2014. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43487-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43487-1_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43486-4

  • Online ISBN: 978-3-662-43487-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation